Concepedia

Carsten Grüllich

CG

Statistics

Publications

56

Citations

2.1K

H-Index

30

Active since

1998

Affiliations

Heidelberg University(Current)

National Center for Tumor Diseases

University Hospital Heidelberg

German Cancer Research Center

University Medical Center Freiburg

Carsten Grüllich is an author at Heidelberg University specializing in medicine, oncology, and immunology.

ORCID

Publications per year

1998–2023

56

Publications

56

Pasotuxizumab, a Bite <sup>®</sup> Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich et al. · Immunotherapy · 2020 · 144 citations · Full text

, , +17

CD95(Fas/APO-1) Signals Ceramide Generation Independent of the Effector Stage of Apoptosis

Carsten Grüllich, M. Cameron Sullards, Zvi Fuks et al. · Journal of Biological Chemistry · 2000 · 85 citations · Full text

, , +17

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity

Rouven Hoefflin, Bernd Lahrmann, Gregor Warsow et al. · Nature Communications · 2016 · 80 citations · Full text

, , +17

Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation

Stefanie Zschäbitz, Felix Lasitschka, Boris Hadaschik et al. · European Journal of Cancer · 2017 · 79 citations

, , +13

Inhibition of 15‐lipoxygenase leads to delayed organelle degradation in the reticulocyte

Carsten Grüllich, Robert M. Duvoisin, Martin Wiedmann et al. · FEBS Letters · 2001 · 73 citations

, , +17

1–5 of 56